Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Names Quest Alumnus S&M VP; NanoString Taps ABI Vet for Marketing VP; VC Shop Hires Ex-Serologicals CEO, CFO to Help Boost Investments

NEW YORK (GenomeWeb News) — Chad Richards has joined Transgenomic as senior vice president of sales and marketing. Richards was national sales director in the Cancer Diagnostics Division at Quest Diagnostics. Before that he was in marketing and sales management at Ventana Medical Systems.

NanoString Technologies has named Lianne McLean vice president of marketing. McLean comes to NanoString from Applied Biosystems, where she was director of global strategic marketing in the Molecular Cell Biology Division. McLean also was involved in marketing whole genome expression arrays, reagents, and model organism arrays at Affymetrix, and was involved in marketing at Roche and at Chiron Diagnostics.  

Louis Tartaglia, who resigned as chief scientific officer of Gene Logic in June, moved into a special advisory role, the company stated in a filing with the Securities and Exchange Commission this week. According to the filing, Tartaglia began his one-year stint as an advisor Sept. 1. Gene Logic will pay him a $25,000 retainer per year plus $150 per hour for his services.

Pharsight this week said it has hired Lars Lindborn to be a senior associate scientist in the company’s Strategic Consulting Services group in Europe. Lindborn was formerly a Pfizer fellow at Uppsala University’s department of pharmaceutical biosciences. He also was a bioinformatics software developer at AstraZeneca.

GeneExpress has appointed Hannah Monds director of business development, in which she will handle licensing for the company’s StaRT-PCR technology and will manage business relations. Monds was previously at AAIPharma, where she was involved in lab analysis of pharmaceuticals and was manager of the company’s Stability Management services.

Private equity firm Genstar Capital has formed a partnership with former Serologicals CEO David Dodd and Bud Ingalls, former CEO and president role at LaRoche Industries, in hopes of accelerating the company’s investments in the life sciences. Before working at Serologicals, Dodd was at Abbott Laboratories, Wyeth-Ayerst Laboratories, Mead Johnson Laboratories, and Solvay Pharmaceuticals. Ingalls has also been chief financial officer of CardioMEMS and vice president of finance and CFO of Serologicals.

Access Genetics has named Paul Hoedeman chief financial officer and Elizabeth Skinner as vice president of legal, quality, and regulatory affairs. Hoedeman recently was CFO of Edwin Watts Golf, and has been vice president of finance at Home Depot, corporate controller at NCR Corporation, and CFO and chief information officer at Allied Signal Aerospace. Skinner was an attorney in private practice and was in-house counsel at Children’s Hospitals and Clinics. She has also been director of regulatory and clinical appeals at Medica. 

 

 



Bill Craumer, who formerly was director of corporate marketing and communications at Illumina, has been named director of investor relations at Applied Biosystems.

 


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.